Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$297,438
-$24,012 QoQ
Shares Held
1,182
-20.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#3,637
of 4,153 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Centerpoint Advisors, LLC holds $2,533,470 across 10 Drug Manufacturers - General names. ABBV ranks #3 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,965 | $1,006,991 | |
| 2 | LLY |
ELI LILLY & Co
|
817 | $979,934 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
1,182 | $297,438 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,035 | $132,997 | |
| 5 | PFE |
Pfizer Inc
|
3,152 | $75,900 | |
| 6 | BIIB |
Biogen Inc.
|
83 | $17,932 | |
| 7 | AMGN |
Amgen Inc
|
28 | $10,139 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
56 | $7,075 |
All Filings in ABBV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $297,438 | 1,182 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $321,450 | 1,478 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $405,569 | 1,775 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $411,909 | 1,779 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $314,625 | 1,695 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $352,622 | 1,683 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $298,536 | 1,680 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $359,018 | 1,818 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $328,289 | 1,914 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $375,672 | 2,063 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $268,872 | 1,735 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $241,030 | 1,617 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $217,319 | 1,613 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $278,419 | 1,747 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $229,809 | 1,422 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $189,370 | 1,411 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $77,652 | 507 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $63,871 | 394 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $52,941 | 391 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $41,853 | 388 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $38,860 | 345 | Shares | Sole | 2021-07-26 | |
| No filing history on record for this holder in this stock. | ||||||